Hikma Pharmaceuticals plans USD1 billion investment to support US unit
(Alliance News) - Hikma Pharmaceuticals PLC has pledged to invest USD1 billion by 2030 to further expand its US manufacturing and R&D capabilities. Read More
Price | 2,010.00p on 18-07-2025 | at 18:50:06
---|---|
Change | 15.00p 0.75% |
Buy | 2,004.00p |
Sell | 2,002.00p |
Buy / Sell HIK Shares |
Last Trade: | Unknown 677.00 at 2,010.00p |
Day's Volume: | 327,430 |
Last Close: | 2,010.00p |
Open: | 1,995.00p |
ISIN: | GB00B0LCW083 |
Day's Range | 1,990.00p - 2,014.00p |
52wk Range: | 1,751.00p - 2,360.00p |
Market Capitalisation: | £4.43b |
VWAP: | 2,007.77276p |
Shares in Issue: | 220.43m |
Hikma Pharmaceuticals (HIK) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 677 | 2,010.00p | OTC Trade |
16:37:53 - 18-Jul-25 |
Unknown* | 39 | 2,010.00p | OTC Trade |
16:37:53 - 18-Jul-25 |
Buy* | 218,404 | 2,010.00p | Suspected BUY Trade |
16:35:13 - 18-Jul-25 |
Sell* | 13 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Sell* | 110 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Sell* | 34 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Sell* | 464 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Sell* | 406 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Sell* | 245 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Sell* | 48 | 2,002.00p | Automatic Execution |
16:29:50 - 18-Jul-25 |
Hikma Pharmaceuticals (HIK) Regulatory News |
||
Date | Source | Headline |
---|---|---|
9th Jul 2025 9:00 am | RNS | Notice of Results |
7th Jul 2025 9:16 am | RNS | Publication of Offering Circular |
9th Jun 2025 3:33 pm | RNS | Director/PDMR Shareholding |
5th Jun 2025 2:05 pm | RNS | Director/PDMR Shareholding |
3rd Jun 2025 1:02 pm | RNS | Director/PDMR Shareholding |
29th May 2025 7:00 am | RNS | Fitch upgrades Hikma to ‘BBB’ |
20th May 2025 2:49 pm | RNS | Director/PDMR Shareholding |
15th May 2025 12:00 pm | RNS | Medium-term Group guidance ahead of US site visit |
8th May 2025 4:35 pm | RNS | Director/PDMR Shareholding |
8th May 2025 10:48 am | RNS | S&P upgrades Hikma to ‘BBB’ |